Table 1.

Sociodemographic and Clinical Correlates Among Users of Methamphetamines, Nonusers, and the Total Study Population (n, %)

	Total study population (n=20 249 026)	Nonusers (n=20 182 827)	Methamphetamine users (n=66 199)	P value
	n (%)
Male sex	9 000 987 (44.4)	8 959 065 (44.4)*	41 922 (63.3)*	<0.01
Age (mean, y ± SD)	…	44.88 ± 19.52	32.94 ± 11.63	<0.01
Race or ethnicity
White	11 347 814 (56.04)	11 311 240 (56.04)	36 574 (55.3)	<0.01
Black	1 483 047 (7.32)	1 479 127 (7.33)	3920 (5.9)	<0.01
Hispanic	5 156 342 (25.46)	5 134 873 (25.44)	21 470 (32.4)	<0.01
Asian/Pacific	1 572 918 (7.77)	1 570 922 (7.78)	1996 (3.0)	<0.01
Native American	30 305 (0.15)	30 098 (0.15)	207 (0.3)	<0.01
Other races not specified	658 599 (3.25)	656 567 (3.25)	2032 (3.1)	<0.01
Cocaine abuse	27 165 (0.13)	23 449 (0.12)	3716 (0.33)	<0.01
Alcohol abuse	140 022 (0.69)	135 691 (0.67)	4331 (6.54)	<0.01
Chronic depression	390 817 (1.93)	383 470 (1.90)	7347 (11.10)	<0.01
Anxiety	296 554 (1.46)	293 439 (1.45)	3115 (4.71)	<0.01
Income quartiles
First	4 890 374 (24.15)	4 867 733 (24.12)	22 641 (34.20)	<0.01
Second	5 055 647 (24.97)	5 036 229 (24.95)	19 428 (29.35)	<0.01
Third	5 173 930 (25.55)	5 159 463 (25.56)	14 467 (21.85)	<0.01
Fourth	5 129 075 (25.33)	5 119 412 (25.37)	9663 (14.60)	<0.01
Hypertension	2 732 890 (13.50)	2 727 149 (13.51)	5741 (8.67)	<0.01
Smoker	791 538 (3.91)	774 249 (3.84)	17 289 (26.12)	<0.01
Obesity	503 752 (2.49)	502 181 (2.49)	1571 (2.37)	0.058
Dyslipidemia	704 687 (3.48)	703 837 (3.49)	850 (1.28)	<0.01
Chronic kidney disease	139 497 (0.69)	139 298 (0.69)	199 (0.30)	<0.01
Diabetes	1 308 196 (6.46)	1 304 482 (6.46)	3714 (5.61)	<0.01

^* P value for difference between nonuser and methamphetamine user populations.